Literature DB >> 9503179

Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain.

L Pizzulli1, A Yang, J F Martin, B Lüderitz.   

Abstract

AIMS: An increase in platelet aggregability is associated with unstable angina and myocardial infarction. Platelet size and activity correlate and mean platelet volume was found to be increased before acute myocardial infarction. We measured the mean platelet volume and platelet count in patients with stable angina, unstable angina and non-cardiac chest pain. METHODS AND
RESULTS: We studied 981 patients (734 men; 247 women) defined clinically as stable angina (n = 688), unstable angina (n = 108) and unstable angina requiring immediate angioplasty (n = 52). After coronary angiography the patients were subdivided into single (n = 269), double (n = 304) and triple-vessel disease (n = 311) and the control group of non-cardiac chest pain (n = 97). There was no significant difference in platelet count between the control group and patients with 1, 2, or 3-vessel disease. However, the platelet size in patients with coronary artery disease was significantly larger (single: 8.7 +/- 1.19 fl; double: 8.7 +/- 1.12 fl; triple-vessel disease: 8.8 +/- 1.18 fl) than the control group (8.2 +/- 0.95 fl) (P < 0.01). Patients with stable angina similarly had no, significant difference in platelet count compared to the control group but did have a significantly increased mean platelet volume (8.7 +/- 1.13; P < 0.01). In contrast, patients with unstable angina had a decreased platelet count (245 +/- 56 x 10/l) compared to either stable angina (262 +/- 62 x 10/l; P < 0.05) or the control group (261 +/- 58 x 10/l; P < 0.05); furthermore, the mean platelet volume (9.4 +/- 1.23 fl) was significantly greater than for stable angina (P < 0.01). Patients with unstable angina requiring immediate PTCA had an even lower platelet count (231 +/- 55 x 10/l) and higher mean platelet volume (10.4 +/- 1.03 fl) (P < 0.01) than the rest of the population with unstable angina.
CONCLUSIONS: In stable angina the platelet count is unchanged compared to patients with normal coronary arteries but the platelet size is increased. However, in unstable angina there is a decrease in platelet count and an even larger increase in platelet size. We interpret this as meaning that unstable angina might be associated or preceded by an increase in platelet destruction rate that is not completely compensated for by an increase in platelet production rate. The large, more reactive platelets might be causally related to an ongoing coronary artery obstruction in unstable angina.

Entities:  

Mesh:

Year:  1998        PMID: 9503179     DOI: 10.1053/euhj.1997.0747

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  50 in total

1.  Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro.

Authors:  Kiran Kumar R Mangalpally; Alan Siqueiros-Garcia; Muthiah Vaduganathan; Jing-Fei Dong; Neal S Kleiman; Sasidhar Guthikonda
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

2.  Mean platelet volume in the patients with cardiac syndrome X.

Authors:  Serkan Cay; Funda Biyikoglu; Gokhan Cihan; Sule Korkmaz
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

3.  Platelet-large cell ratio and the extent of coronary artery disease: results from a large prospective study.

Authors:  Giuseppe De Luca; Matteo Santagostino; Gioel Gabrio Secco; Ettore Cassetti; Livio Giuliani; Lorenzo Coppo; Alon Schaffer; Angelica Fundaliotis; Sergio Iorio; Luca Venegoni; Giorgio Bellomo; Paolo Marino
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

4.  Management of the metabolic syndrome in cardiovascular disease.

Authors:  Wai Ping Alicia Chan; Aaron Leonid Sverdlov; John David Horowitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

5.  Mean platelet volume levels in the presence of angiographically documented peripheral artery disease.

Authors:  Ozlem Arican Ozluk; Ibrahim Ber; Tezcan Peker; Mustafa Yilmaz; Erhan Tenekecioglu; Kemal Karaagac; Fahriye Vatansever
Journal:  Int J Clin Exp Med       Date:  2015-02-15

6.  Association between mean platelet volume and autonomic nervous system functions: Increased mean platelet volume reflects sympathetic overactivity.

Authors:  Ozcan Ozdemir; Mustafa Soylu; Omer Alyan; Bilal Geyik; Ahmet Duran Demir; Dursun Aras; Gökhan Cihan; Göksel Cagirci; Fehmi Kacmaz; Yücel Balbay; Hatice Sasmaz; Sule Korkmaz
Journal:  Exp Clin Cardiol       Date:  2004

7.  Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention.

Authors:  Tadanao Higaki; Satoshi Kurisu; Noriaki Watanabe; Hiroki Ikenaga; Takashi Shimonaga; Toshitaka Iwasaki; Naoya Mitsuba; Ken Ishibashi; Yoshihiro Dohi; Yukihiro Fukuda; Yasuki Kihara
Journal:  Heart Vessels       Date:  2014-11-09       Impact factor: 2.037

8.  Letter by Garcia A, et al. regarding article "The clinical evaluation of the CADence device in the acoustic detection of coronary artery disease".

Authors:  Artemio García-Escobar; Juan Manuel Grande; Fernando Cabestrero
Journal:  Int J Cardiovasc Imaging       Date:  2018-11-09       Impact factor: 2.357

9.  Do immature platelet levels in chest pain patients presenting to the emergency department aid in the diagnosis of acute coronary syndrome?

Authors:  M A Berny-Lang; C E Darling; A L Frelinger; M R Barnard; C S Smith; A D Michelson
Journal:  Int J Lab Hematol       Date:  2014-05-08       Impact factor: 2.877

10.  Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.

Authors:  Guldem Kilciler; Halil Genc; Serkan Tapan; Fatih Ors; Muammer Kara; Nuri Karadurmus; C Nuri Ercin; Yildirim Karslioglu; Selim Kilic; Sait Bagci; M Kemal Erbil; Teoman Dogru
Journal:  Ups J Med Sci       Date:  2010-08-23       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.